The DCCT has now entered phase III, consisting of a full-scale clinical trial (about 1000 patients) of the effects of diabetic control on early micro and macrovascular complications of diabetes. Patients are randomized to either experimental or standard treatment groups.
Showing the most recent 10 out of 497 publications